Skip to main content
. 2019 May 7;12:40. doi: 10.1186/s13048-019-0511-7

Fig. 3.

Fig. 3

Comparisons of survival outcomes in the wild-type BRCA group (upper) and in the BRCA mutation group (lower) according to the primary treatment strategy. a, c Overall survival. b, d Progression-free survival